Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR5 | Q9H1C0 | 6/20 | 0.97 |
| ▸ | LPAR1 | Q92633 | 13/20 | 0.67 |
| ▸ | LPAR3 | Q9UBY5 | 10/20 | 0.67 |
| ▸ | LPAR2 | Q9HBW0 | 7/20 | 0.59 |
| ▸ | LPAR4 | Q99677 | 5/20 | 0.59 |
| ▸ | LPAR6 | P43657 | 4/20 | 0.59 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | P2RY10 | O00398 | 1/20 | 0.54 |
| ▸ | CES2 | O00748 | 1/20 | 0.51 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL250888 | 1.00 | LPAR5 (0.97) | LPAR5LPAR1LPAR3LPAR2LPAR4 | |
| SCHEMBL258161 | 0.98 | LPAR5 (1.00) | LPAR5LPAR1LPAR3LPAR2LPAR4 | |
| SCHEMBL7820593 | 0.98 | LPAR5 (1.00) | LPAR5LPAR1LPAR3LPAR2LPAR4 | |
| SCHEMBL258032 | 0.98 | LPAR5 (1.00) | LPAR5LPAR1LPAR3LPAR2LPAR4 | |
| SCHEMBL258118 | 0.98 | LPAR5 (1.00) | LPAR5LPAR1LPAR3LPAR2LPAR4 | |
| SCHEMBL7829804 | 0.98 | LPAR5 (1.00) | LPAR5LPAR1LPAR3LPAR2LPAR4 | |
| SCHEMBL12621099 | 0.98 | LPAR5 (1.00) | LPAR5LPAR1LPAR3LPAR2LPAR4 | |
| SCHEMBL258094 | 0.98 | LPAR5 (1.00) | LPAR5LPAR1LPAR3LPAR2LPAR4 | |
| SCHEMBL28064781 | 0.98 | LPAR5 (1.00) | LPAR5LPAR1LPAR3LPAR2LPAR4 | |
| SCHEMBL26603866 | 0.98 | LPAR5 (1.00) | LPAR5LPAR1LPAR3LPAR2LPAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111154724-A | Extracted plant lipids comprising docosahexaenoic acid | 联邦科学技术研究组织 | 2020-05-15 | — | — | CN | claimed |
| US-20120270250-A1 | TEST SYSTEM FOR MEASURING MEST ACTIVITY AS WELL AS METHODS AND USES INVOLVING THE SAME | SANOFI (FR) | 2012-10-25 | — | — | US | claimed |
| EP-2446050-A1 | TEST SYSTEM FOR MEASURING MEST ACTIVITY AS WELL AS METHODS AND USES INVOLVING THE SAME | SANOFI (FR) | 2012-05-02 | — | — | EP | claimed |
| EP-2283137-A1 | RECOMBINANT CELLS AND METHODS FOR HYDROXYLATING FATTY ACIDS | Commonwealth Scientific and Industrial Research Organisation (AU) | 2011-02-16 | — | — | EP | claimed |
| WO-2010149780-A1 | TEST SYSTEM FOR MEASURING MEST ACTIVITY AS WELL AS METHODS AND USES INVOLVING THE SAME | SANOFI-AVENTIS (FR) | 2010-12-29 | — | — | WO | claimed |
| EP-2267152-A1 | Test system for measuring MEST activity as well as methods and uses involving the same | Sanofi-Aventis (FR) | 2010-12-29 | — | — | EP | claimed |
| WO-2009129582-A1 | POLYPEPTIDES AND METHODS FOR PRODUCING TRIACYLGLYCEROLS COMPRISING MODIFIED FATTY ACIDS | COMMONWEALTH SCIENTIFIC INDUSTRIAL RESEARCH ORGANISATION (AU) | 2009-10-29 | — | — | WO | claimed |
| WO-2009129583-A1 | RECOMBINANT CELLS AND METHODS FOR HYDROXYLATING FATTY ACIDS | COMMONWEALTH SCIENTIFIC INDUSTRIAL RESEARCH ORGANISATION (AU) | 2009-10-29 | — | — | WO | claimed |
| EP-1615937-A2 | ANALOGS OF LYSOPHOSPHATIDIC ACID AND METHODS OF MAKING AND USING THEREOF | University of Utah Research Foundation (US) | 2006-01-18 | — | — | EP | claimed |
| WO-2004092188-A2 | ANALOGS OF LYSOPHOSPHATIDIC ACID AND METHODS OF MAKING AND USING THEREOF | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2004-10-28 | — | — | WO | claimed |
| US-5827831-A | Lipid nucleotide analog prodrugs for oral administration | NEXSTAR PHARMACEUTICALS, INC. (US) | 1998-10-27 | — | — | US | claimed |
| WO-2023141470-A2 | IMMUNOMODULATORY LIPIDS AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-07-27 | — | — | WO | disclosed |
| WO-2023102425-A1 | METHODS FOR DETERMINING OPIOID RESPONSIVENESS IN THE TREATMENT OF PAIN | EAST CAROLINA UNIVERSITY (US) | 2023-06-08 | — | — | WO | disclosed |
| US-20170211013-A1 | LIPID COMPRISING LONG CHAIN POLYUNSATURATED FATTY ACIDS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2017-07-27 | — | — | US | disclosed |
| US-20170088842-A1 | GENETICALLY MODIFIED FUNGI AND THEIR USE IN LIPID PRODUCTION | TEKNOLOGIAN TUTKIMUSKESKUS VTT (FI) | 2017-03-30 | — | — | US | disclosed |
| EP-1278858-A2 | 46743 AND 27417, NOVEL HUMAN ACYLTRANSFERASE FAMILY MEMBERS AND USES THEREFOR | Millennium Pharmaceuticals, Inc. (US) | 2003-01-29 | — | — | EP | disclosed |
| US-20020016449-A1 | 46743 and 27417, novel human acyltransferase family members and uses therefor | MILLENNIUM PHARMACEUTICALS, INC. | 2002-02-07 | — | — | US | disclosed |
| US-20020007499-A1 | DNA SEQUENCE ENCODING PLANT 2-ACYLTRANSFERASE | GENE SHEARS PTY. LIMITED (AU) | 2002-01-17 | — | — | US | disclosed |
| WO-2001073051-A2 | 46743 AND 27417, NOVEL HUMAN ACYLTRANSFERASE FAMILY MEMBERS AND USES THEREFOR | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2001-10-04 | — | — | WO | disclosed |
| US-6210967-B1 | NUCLEOTIDE SEQUENCES CODING HUMAN PHOSPHATIDIC ACID BINDING PROTEIN; FOR TREATMENT AND PREVENTION OF CANCER, PLATELET AGGREGATION, VASCULAR RESTENOSIS, ARTHRITIS, WOUND HEALING, TISSUE REGENERATION, COAGULATION, OSTEOPOROSIS AND SCARING | SYNAPTIC PHARMACEUTICAL CORPORATION | 2001-04-03 | — | — | US | disclosed |